Search

You searched for "Renal"

707 results found

Elements of AI

7 January 2020 | | URO - Technology
Given that a recent issue of Urology News focused on artificial intelligence (AI) in urology and potential problems it might bring, this month’s digital review focuses on a free course in artificial intelligence. Elements of AI (www.elementsofai.com) is a free...

Bike4TUF goes local to raise vital funds and support patients

7 October 2020 |
There was no stopping urologists from raising vital funds for charity as they cycled more than 2000 miles to support The Urology Foundation (TUF). The annual Bike4TUF event saw 24 participants cycle in teams of six across Manchester, Canterbury, London,...

Action Bladder Cancer UK awards grants for bladder cancer research

5 September 2024 | URO - Urologic Oncology
Action Bladder Cancer UK has granted funding to enable vital research into bladder cancer as part of its annual ABC UK Improving Outcomes for Patients Programme (https://actionbladdercanceruk.org/abc-uk-grants/). The five grant recipients will undertake significant studies, ranging from the analysis of...
European Urology journal cover image

One cycle of adjuvant chemotherapy in tumours of the testis

4 May 2020 | | URO - Urologic Oncology
Following a radical orchiectomy, current UK practice for newly diagnosed, high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis (NSCGCTT) is either two cycles of adjuvant chemotherapy with bleomycin, etoposide, cisplatin (BE360Px2) or surveillance with BE500Px3 on...

Patient portals

1 May 2014 | | URO - Technology
In May 2012, the Department of Health published its information strategy ‘Power of information’ which aims to put us all in control of the health and care information we need [1]. As a part of its information strategy a key...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

7 March 2019 | Awards & Conferences
Partnership with Academia Award Winner: Femeda Ltd Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from the...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

7 March 2019 | Research & Development
Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from...

New ultrasound imaging technique reliably spots prostate cancer, initial patient trial reveals

16 January 2025
A groundbreaking new imaging approach developed by researchers at Heriot-Watt University has shown ‘extremely encouraging’ results in early-stage clinical trials on prostate cancer at the Western General Hospital in Edinburgh, Scotland. The ongoing clinical trial demonstrated an initial 94% sensitivity...

Can dogs smell prostate cancer?

4 March 2025 | | URO - Urologic Oncology
For centuries we have known that man’s best friend has an exceptional sense of smell. ‘Sniffer’ dogs are found in a wide range of roles, including drug and explosive detection as part of airport security, helping emergency services locate survivors...

In conversation with Roger Kirby

3 September 2020 | URO - Core Urology
We were delighted to catch up with Roger Kirby, new President of the RSM, about his illustrious career in urology. Can you tell us a little bit about what led you into the field of urology and what have been...

So you want to go on a Fellowship: part 1

1 January 2016 | | URO - Core Urology
Look out for part 2 of this series later in 2016 when the author will discuss settling into the research role of his fellowship and will reflect on his first year overseas. This is the first in a series of...

The final hurdle: the consultant interview

1 July 2014 | | URO - Core Urology
The consultant interview is undoubtedly the most important exam you’ll ever sit; but curiously even the best and most motivated trainee becomes somewhat fatalistic when approaching this, the most important of all hurdles. Gone are the days when deals were...